Endocrinology Vol. 139, No. 7 3193-3201
Copyright © 1998 by The Endocrine Society
Sexual Differentiation of Aromatase Activity in the Rat Brain: Effects of Perinatal Steroid Exposure1
Charles E. Roselli and
Scott A. Klosterman
Department of Physiology and Pharmacology, Oregon Health
Sciences University, Portland, Oregon 97201
Address all correspondence and requests for reprints to: Dr. Charles E. Roselli, Department of Physiology and Pharmacology L334, Oregon Health Sciences University, 3181 S.W. Sam Jackson Park Road, Portland, Oregon 97201-3098. E-mail: rosellic{at}OHSU.edu
 |
Abstract
|
|---|
Androgens regulate aromatase activity in the medial preoptic area and
other components of the brain circuit that mediates male sexual
behavior. The levels of aromatase activity within these brain regions
are greater in males than in females. As the activation of copulation
requires aromatization of testosterone to estradiol, this quantitative
enzymatic difference between sexes could contribute to the greater
behavioral response displayed by males. The present study was designed
to test the hypothesis that gender differences in brain aromatase
activity of adult rats are dependent on the sexual differentiation of
the brain that occurs during perinatal exposure to gonadal hormones.
Aromatase activity was measured in vitro in
microdissected brain samples using a sensitive radiometric assay. We
examined the effect of pre- and postnatal treatment with testosterone
propionate or diethylstilbestrol on basal levels and androgen
responsiveness of aromatase in adults. In addition, we examined what
effect prepubertal gonadectomy exerts on enzyme regulation. Our results
demonstrate that perinatal treatments with gonadal hormones that are
known to differentiate sexual behavior can completely masculinize the
capacity for aromatization in the adult female. The process that
differentiates aromatase expression appears to depend on androgen
exposure and, in part, local estrogen synthesis, as diethylstilbestrol
was able to substitute for testosterone propionate. We also observed
that prepubertal gonadectomy reduced the levels of aromatase activity
measured in adult brain, suggesting that gonadal hormones that are
secreted during puberty may enhance the expression of aromatase
activity in adulthood. From this study, we conclude that testosterone
and/or its estrogenic metabolites act on the developing brain to
determine the gender-specific capacity for aromatization and to
regulate androgen responsiveness within components of the neural
circuitry that mediates male sexual behavior.
 |
Introduction
|
|---|
ONE MANIFESTATION of a male-differentiated
brain is an enhanced responsiveness to hormonal activation of
male-typical sexual behaviors by testosterone (T) (1, 2, 3, 4). It is well
established that this behavioral sexual dimorphism is determined at
least in part by exposure to androgen during the critical period for
sexual differentiation of neural tissue (5). The critical period in
rats begins in late gestation and continues into the first week to 10
days of postnatal life (5). Male rats that are deprived of androgen
exposure during the critical period by gonadectomy (Gdx) before day 10
of age exhibit an impaired behavioral response to T as adults (6). On
the other hand, female rats that are exposed to T before day 10 of age
and injected again with T as adults display levels of copulatory
behaviors comparable to those of gonad-intact genetic males (7, 8, 9).
However, it is not androgen per se that is responsible for
masculinizing the brain. According to the aromatization hypothesis, the
effects of T on behavior depend to a large extent upon its cellular
conversion to estrogen by cytochrome P450 aromatase in the rat brain
(5).
Behavioral gender differences in androgen responsiveness are presumably
related to specific morphological and/or biochemical brain
characteristics that differ between males and females. Several brain
regions involved in the regulation of sexual behavior are known to be
sexually dimorphic (10). There is evidence that perinatal androgen
exposure masculinizes the brain by altering the number of neurons in
specific brain areas, as well as their connectivity and
neurotransmitter content (10, 11, 12, 13). Moreover, region-specific sex
differences in steroid receptor binding [protein and messenger RNA
(mRNA)] have been demonstrated in the rat brain. Males have greater
androgen receptor concentrations and/or greater numbers of androgen
receptor-containing neurons within brain areas mediating the hormonal
activation of sexual behavior by androgen (2, 14, 15, 16). As with brain
differentiation, the conversion of T to estradiol by aromatase is an
important part of the pathway mediating copulatory behaviors in adult
rats (17). Thus, it is also possible that the capacity for conversion
of T to active estrogenic metabolites in the adult mammalian brain is
influenced by perinatal exposure to gonadal steroids.
Aromatase activity (AA) is highest within the medial amygdala (MA), bed
nucleus of the stria terminalis (BNST), medial preoptic nucleus (MPN),
periventricular preoptic area (PVPOA), anterior hypothalamus (AH), and
ventromedial nucleus of the hypothalamus (VMN) of adult rats (18, 19).
These nuclei in large part comprise the brain circuitry that regulates
masculine sexual behavior (20). AA in these nuclei is stimulated by
androgens and has been referred to as androgen dependent (19). The
induction of aromatase by T is mediated through an androgen receptor
mechanism that regulates aromatase mRNA levels (21, 22). Expression of
androgen-dependent AA in the adult brain is greater in males than in
females because of normal sex differences in circulating androgen
levels (19). However, the mechanism of enzyme induction is also
sexually dimorphic because equivalent physiological doses of T
stimulate aromatase to a greater extent in males than in females (2).
Dose-response studies indicate that the sex difference is apparent over
a range of circulating T concentrations and constitutes a gender
difference in the efficacy of T stimulation (23). Measurements of
aromatase mRNA in androgen-treated gonadectomized (Gdx) rats
demonstrate that the sex difference in regulation is exerted
pretranslationally (24). Taken together, these results suggest a
sexually dimorphic mechanism that could potentially limit the action of
T in females and may in part account for the enhanced expression of
T-stimulated sexual behaviors in males.
A major issue that needs to be resolved is whether the adult gender
difference in the expression and regulation of brain aromatase is
developmentally determined. Therefore, the present study tested the
hypothesis that exposure to T during the critical perinatal period for
sexual differentiation accounts for the sex difference in the neural
expression of androgen-regulated aromatase in adults. In addition, as
the aromatase hypothesis predicts that androgen-derived estrogens are
responsible for sexual differentiation in rats (17), we examined
whether perinatal estrogen exposure is also capable of altering the
phenotypic expression of aromatase in the adult. Finally, because it
has been suggested that puberty is associated with an increase in
neural responsiveness to T (25, 26, 27), we examined what effect, if any,
prepubertal Gdx exerts on enzyme regulation in adults. The present
study has addressed these issues by using a micropunch technique to
measure basal and androgen-stimulated AA in a group of limbic and basal
forebrain nuclei that are known to be involved in the modulation of
androgen-dependent behaviors and neuroendocrine functions. Comparisons
are made among control males, control females, and females treated
perinatally with androgen or estrogen.
 |
Materials and Methods
|
|---|
Animals
Pregnant Sprague-Dawley rats were obtained from Simonsen
Laboratories (Gilroy, CA) and timed to arrive on gestational day 14 or
15. The determination of the day of conception was designated
gestational day 0 (GD0) was carried out by the supplier and was defined
by the presence of a copulatory plug. The rats were housed individually
and maintained on a 12-h light, 12-h dark schedule. Food and water were
available ad libitum. All experimental procedures were
conducted in accordance with the Guide for the Care and Use of
Laboratory Animals as adopted by the NIH and were approved by the
institutional animal care and use committee of the Oregon Health
Sciences University.
Experimental protocol
The experimental protocol is diagramed in Fig. 1
. Rat fetuses were treated prenatally
with daily sc injections of testosterone propionate (TP; 2 mg/100 µl
oil), diethylstilbestrol (DES; 10 µg/100 µl oil), or 100 µl
sesame oil vehicle to pregnant dams from GD16 to GD19. At birth, all
pups were weighed, and their anogenital distances were measured with a
micrometer. When possible, litters were adjusted to no more than eight
pups. After birth, the pups were given sc injections of TP (0.1 mg/50
µl oil), DES (1 µg/50 µl oil), or 50 µl sesame oil vehicle each
day beginning on the day of delivery and continuing through the fifth
postnatal day (PD). All pups in a litter were given the same treatment
and were kept separate from all other litters. The five perinatal
treatment groups were: 1) control
, males treated pre- and
postnatally with the sesame oil vehicle; 2) control
, females
treated pre- and postnatally with the sesame oil vehicle; 3) perinatal
TP
, females treated pre- and postnatally with TP; 4) postnatal TP
, females treated prenatally with vehicle and postnatally with TP;
and 5) perinatal DES
, females treated pre- and postnatally with
DES. These treatments were chosen because they were shown previously to
masculinize brain anatomy and adult sexual behaviors (7, 8, 28).

View larger version (14K):
[in this window]
[in a new window]
|
Figure 1. Experimental design and treatment time line. Rat
fetuses were treated prenatally with daily sc injections of TP (2
mg/100 µl oil), DES (10 µg/100 µl oil), or 100 µl sesame oil
vehicle to pregnant dams from GD16 to GD19. After birth, the pups were
given sc injections of TP (0.1 mg/50 µl oil), DES (1 µg/50 µl
oil), or 50 µl sesame oil each day beginning on the day of delivery
and continuing through the fifth postnatal day (PD). All pups in a
litter were given the same treatment and were kept separate from all
other litters. The five perinatal treatment groups were: control ,
males treated pre- and postnatally with the sesame oil vehicle; control
, females treated pre- and postnatally with the sesame oil vehicle;
perinatal TP , females treated pre- and postnatally with TP;
postnatal TP , females treated prenatally with vehicle and
postnatally with TP; and perinatal DES , females treated pre- and
postnatally with DES. Pups were weaned and weighed on PD 24 and housed
according to sex. Group A rats were Gdx on PD 30 before the onset of
puberty. Group B rats were Gdx on PD 56 as adults. On PD 56, half of
the rats in both groups received 3-cm SILASTIC brand capsules filled
with crystalline T, whereas the other half were sham implanted. The
rats were killed 7 days later, and basal (Gdx) and androgen-stimulated
(Gdx+T) levels of AA were measured in microdissected brain nuclei.
|
|
Pups were weaned and weighed on PD 24, and housed according to sex. To
determine the effect of prepubertal gonadectomy on the capacity for
aromatization in brain, half of the juvenile rats in each treatment
group were bilaterally Gdx under ketamine-xylazine anesthesia on PD 30
before the onset of puberty. On PD 56, the remaining rats in each
treatment group were Gdx. At this time half of the rats in both the
juvenile Gdx and adult Gdx groups received 3-cm SILASTIC brand capsules
(Dow Corning, Midland, MI) filled with crystalline T, and the remaining
rats were sham implanted. This dose of T produces hormone levels
typical of an adult male rat (29) and was used in the present
experiment to compare T-stimulated AA in males and females. Seven days
later, all of the rats were decapitated, and their brains were rapidly
removed and frozen on dry ice. The brains were stored at -80 C until
they were microdissected and assayed for AA. Trunk blood was collected,
and serum was harvested for determination of circulating T
concentrations. Generally, brains from Gdx and Gdx plus T-treated rats
from all perinatal treatment groups (n = 20) were processed
together to measure AA. A total of 124 rats were used to complete the
study; each group contained 47 animals.
Tissue dissections
Frozen brains were sectioned coronally at 300-µm intervals
beginning where the anterior commissure crosses the midline and
extending caudally 3.6 mm as depicted in the brain map of Palkovits and
Brownstein (30). The tissue sections were thaw mounted onto glass
microscope slides and stored overnight at -80 C. Selected brain nuclei
and regions were dissected bilaterally using 500- and 1000-µm
calibrated stainless steel cannulas, as described previously (19). The
tissue punches were expelled into 500-µl propylene microtubes and
chilled on ice until homogenized.
AA assay
Tissue punch dissections collected from individual animals were
homogenized using a tissue sonicator (E/MC Corp., Hauppauge, NY) in 125
µl phosphate buffer (10 mM
KH2PO4, 100 mM KCl, 1
mM EDTA, and 1 mM dithiothreitol, pH 7.4).
Aliquots of these homogenates (100 µl) were then incubated for 1
h at 37 C with [1ß-3H]androstenedione (New England
Nuclear-Dupont, Boston, MA; SA, 24.1 Ci/mmol). AA was estimated by
quantifying the amount of 3H2O generated by the
stereospecific loss of the C-1ß tritium, which is proportional to the
amount of estrogen formed (31). This assay has been validated in our
laboratory, and the procedural details have been described previously
(31). Protein concentrations were determined using the Lowry method
(32). AA was expressed as femtomoles of 3H2O
produced per h/mg protein.
Testosterone assay
Trunk blood was collected after decapitation and allowed to clot
at 4 C overnight. They were then centrifuged (1500 x g
for 30 min), and sera were harvested. T levels were measured in
individual samples by RIA after extraction and chromatography on
Sephadex LH-20 using previously described methodologies (33). All
samples were assayed in duplicate in a single RIA. The percent
recovery, water blanks, and intraassay coefficient of variation were
79%, 0.7 pg/tube, and 7.3%, respectively.
Statistical analysis
The AA data for each brain nucleus were analyzed by parametric
3 x 3 ANOVA (perinatal treatment x age at castration
x adult treatment). When a significant main effect of perinatal
treatment was found in a tissue (P < 0.05), multiple
one-way ANOVAs were performed across treatment groups.
Post-hoc comparisons were then made between perinatal
treatments with post-hoc Newman-Keuls tests and were
considered significant at P < 0.05 (34).
 |
Results
|
|---|
Effects of perinatal treatments on T-stimulated AA in brain
punches
Three-way ANOVA revealed significant main effects of perinatal
treatment, age at castration, and adult treatment on AA in the BNST,
MPN, PVPOA, and VMN. A significant interaction between perinatal
treatment and adult treatment was also found in PVPOA and VMN. No other
significant interactions were revealed. The results in these four
tissues are summarized in Figs. 2
-5,
respectively. In each figure, A shows the results from rats Gdx on
PD30, and B shows the results for rats Gdx on PD56. To simplify the
data presentation, only comparisons of perinatal treatment groups with
control males and control females are noted in the figures. As
expected, adult T treatments significantly stimulated AA in these
tissues regardless of prior perinatal treatment (compare
gray vs. black bars) or age at
castration (compare A, Gdx on PD 30, with B, Gdx on PD 56). The
induction of AA by T was significantly greater in control males than in
control females. In the prepubertal Gdx group, the percentages by which
AA levels in males was greater than those in females were 174% (BNST),
154% (MPN), 212% (PVPOA), and VMN (122%). In the adult Gdx group,
the percentages by which AA levels in males were greater than those in
females were 134% (BNST), 212% (MPN), 184% (PVPOA), and 143% (VMN).
In BNST, MPN, and PVPOA, females that were treated perinatally with TP
or postnatally only with TP, exhibited significantly greater levels of
T-stimulated AA than control females, whereas T-stimulated AA levels in
these groups were not significantly different from levels in control
males. This effect was observed regardless of whether the rats were Gdx
on PD 30 or as adults. In VMN, a significant effect of perinatal and
postnatal TP treatments was observed only in rats that were Gdx
as adults. Perinatal DES treatment masculinized the T-stimulated
induction of AA in BNST, MPN, and PVPOA, but not in VMN. Gonadectomized
(i.e. unstimulated) levels of AA did not differ between
perinatal treatment groups in the MPN and VMN. However, in the PVPOA
and BNST, AA levels in control males, perinatal TP-treated females, and
postnatal TP-treated females were generally higher than the levels in
control females and perinatal DES-treated females. In general, both
Gdx and T-stimulated levels of AA in all four tissues were higher
in rats Gdx at 56 days of age (Figs. 2B
5B) than in rats Gdx at 30
days of age (Figs. 2A
5A), which accounts for the significant main
effect due to age at Gdx.

View larger version (30K):
[in this window]
[in a new window]
|
Figure 2. Effects of perinatal treatments on T-stimulated AA
in the BNST. A, Rats Gdx on PD30. B, Rats Gdx on PD56. All rats
received sc T-filled SILASTIC implants (30 mm) on PD56 and were killed
1 week later on PD 63. See Materials and Methods for
descriptions of the perinatal treatment groups. Data are presented as
the mean (bars) ± SEM
(lines; n = 47/group). Three-way ANOVA revealed
significant main effects of perinatal treatment (F4,104 =
7.68; P < 0.0001), age at castration
(F1,104 = 7.12; P < 0.01, and adult T
treatment (F1,104 = 183; P < 0.0001)
on AA. Newman-Keuls post-hoc comparisons: §§,
P < 0.05 vs. sham control ; ,
P < 0.05 vs. sham control ; §,
P < 0.05 vs. T-treated control ;
, P < 0.05 vs. T-treated control
.
|
|
The results for the anterior hypothalamus and medial amygdala are
summarized in Figs. 6
and 7
, respectively. Three-way ANOVA revealed
a significant main effect of adult T treatment, but no effect of
perinatal treatment or age of castration in these tissues. In general,
T treatment stimulated AA in adults regardless of any prior perinatal
treatment (compare gray vs. black
bars) or pubertal treatments (compare A, Gdx on PD 30, with B, Gdx
on PD 56).

View larger version (33K):
[in this window]
[in a new window]
|
Figure 6. Effects of perinatal treatments on T-stimulated AA
in the AH. A, Rats Gdx on PD30. B, Rats Gdx on PD56. Data are presented
as the mean (bars) ± SEM
(lines; n = 47/group). Three-way ANOVA revealed
significant main effects of adult T treatment (F1,102 =
44.96; P < 0.0001) only.
|
|

View larger version (33K):
[in this window]
[in a new window]
|
Figure 7. Effects of perinatal treatments on T-stimulated AA
in the MA. A, Rats Gdx on PD30. B, Rats Gdx on PD56. Data are presented
as the mean (bars) ± SEM
(lines; n = 47/group). Three-way ANOVA revealed
significant main effects of adult T treatment (F1,103 =
63.34; P < 0.0001) only.
|
|
Effects of perinatal treatments on anogenital distances, body
weights, and genitalia
The average anogenital distances and body weights of the
experimental groups on PD 63 are shown in Fig. 8
. There was a significant effect of
perinatal treatment on anogenital distances, but no effect of age at
castration or adult treatment. In general, anogenital distance was
greatest in control males, intermediate in females treated peri- or
postnatally with TP, and lowest in control females and females treated
perinatally with DES. There was a significant effect of perinatal
treatment group, age at castration, and adult treatment on body weight,
with a significant interaction between perinatal treatment and age at
castration (Fig. 9
). In general, control
males weighed more than any other treatment group. However, females
that were treated postnatally with TP or perinatally with DES and
castrated as adults were significantly heavier than control females,
but were not as heavy as control males (Fig. 9B
). Females that were
gonadectomized prepubertally weighed more than their counterparts that
were gonadectomized as adults.

View larger version (34K):
[in this window]
[in a new window]
|
Figure 8. Effects of perinatal treatments on anogenital
distances at the time of death (63 days old). Data are presented as the
mean (bars) ± SEM (lines;
n = 47/group). Three-way ANOVA revealed significant main effects
of perinatal treatment (F4,99 = 215, P <
0.0001). Newman-Keuls post-hoc comparisons were made between
perinatal treatment groups. See Fig. 2 for symbol designations.
|
|

View larger version (37K):
[in this window]
[in a new window]
|
Figure 9. Effects of perinatal treatments on body weights at
the time of death (63 days old). Data are presented as the mean
(bars) ± SEM (lines; n
= 47/group). Three-way ANOVA revealed significant main effects of
perinatal treatment (F4,104 = 45, P < 0.0001),
age of castration (F1,104 = 52, P < 0.0001, and
adult T treatment (F1,104 = 7.6, P < 0.01), and
a significant interaction between perinatal treatment and age of
castration (F4,104 = 10.8, P < 0.0001).
Newman-Keuls post-hoc comparisons were made between
perinatal treatment groups. See Fig. 2 for symbol designations.
|
|
Females that received perinatal TP were phenotypical masculinized. They
exhibited an enlarged clitoris that was indistinguishable visually from
the penis of the normal male. They also possessed prostates and seminal
vesicles in addition to a uterus and ovaries. Adult androgen treatment
stimulated the growth of the male-typical glands. The clitori of
females that received postnatal TP were slightly enlarged compared to
those of normal females. Postnatal TP females did not possess
male-typical internal genitalia. The clitoris and uterus of females
that were treated with DES perinatally were not visually different from
those of normal females.
Serum T levels
The levels of serum T are summarized in Fig. 10
. Equivalent levels of T were
achieved in all groups 1 week after Gdx and androgen treatment.
However, females treated with TP perinatally or postnatally exhibited a
slight, but significant, elevation in serum T levels in the sham group
Gdx at 30 days of age.

View larger version (26K):
[in this window]
[in a new window]
|
Figure 10. Serum testosterone concentrations (mean ±
SEM) in Gdx rats that underwent sham surgery or received sc
SILASTIC implants (30 mm) filled with crystalline T. Two-way ANOVA
revealed significant effect of adult treatment (F9,104 =
1701, P < 0.0001) but not perinatal treatment or age of
castration.
|
|
 |
Discussion
|
|---|
The present experiment demonstrates that manipulation of androgen
levels during perinatal development can permanently alter the
gender-specific capacity for aromatization within components of the
neural circuitry that mediates male sexual behavior. Extended exposure
of genetic females to TP during gestational days 1619 and PD 15
increased the subsequent expression of AA in adulthood to levels
characteristic of genetic males. However, treatment of genetic females
with TP from PD1PD5 also completely masculinized the capacity for
aromatization, suggesting that the critical period for this effect
encompasses the first week of life. These effects on aromatase
expression are temporally correlated with the critical developmental
period during which sexual behaviors and neural structures are sexually
differentiated in rats (5) and lend support to the hypothesis that
maturation of aromatase-containing neurons is a differentiated
characteristic of the male brain. Our results further indicate that
although TP was able to substitute fully for testes and its secretions
in determining the capacity for neural aromatization, aspects of its
effect may well be mediated by locally produced estrogen. This
conclusion is based on our observation that perinatal treatment with
the synthetic estrogen, DES, in large part mimicked the effect of
perinatal TP treatment. Perinatal DES exposure of genetic females
increased the androgen-induced expression of AA in adulthood to the
levels observed in genetic males. Thus, these results indicate that the
conversion of androgens into estrogens probably plays a major role in
the differentiation of aromatase neurons.
We demonstrated that the organizational effects of androgen and
estrogen are brain region specific. An effect on the expression of
androgen-stimulated AA was evident in the BNST, MPN, PVPOA, and VMN,
but not in the AH and MA. These results generally agree with our
previous studies that identified gender differences in the induction of
brain aromatase by T within these same nuclei (2, 23). Our results
confirm and extend the work of Steimer and Hutchison (35), who
demonstrated that the sex difference in the induction of aromatase in
the preoptic area of rats is abolished by neonatal Gdx and exposure to
TP from PD 2 to 70. However, in this early study, neonatal Gdx and
extended treatment with TP appeared to substantially decrease the
responses of both sexes to TP compared with that of normal adult males.
In contrast, the perinatal treatments used in the present experiment
were sufficient to completely masculinize the expression of AA, so that
the enzyme activity in hormone-treated genetic females was equivalent
to that in control males.
The induction of AA by T is transcriptionally mediated through a
specific androgen receptor mechanism (36). Therefore, one important
inference that can be drawn from the current study is that the
perinatal exposure to androgen permanently alters the adult
responsiveness to T. Moreover, the cellular basis for the effect of
early androgen and estrogen exposure on androgen-dependent aromatase
expression may relate in part to the differentiation of androgen
receptor-positive neurons or their connections. Consistent with this
idea, the distribution of androgen receptors and androgen-dependent
aromatase exhibit an extensive regional overlap in the rat brain
(37, 38, 39, 40), and sex differences in androgen receptor concentrations are
found largely within the same brain regions as sex differences in
aromatase (2).
In the current study, significant sex differences in the expression of
basal levels of AA were found in the BNST and PVPOA of Gdx adults.
Basal levels of aromatase were significantly higher in control males
than in control females, but were not significantly different from
those in females treated perinatally with TP. Sex differences in AA
that are present after Gdx could be due to gender differences in
androgens produced by the adrenals, but no sex-related differences in
plasma T were detected in the Gdx sera in this study. Moreover, in a
preliminary unpublished study, we did not detect differences between
Gdx and Gdx-adrenalectomized rats in the levels of AA measured in brain
punch samples. Thus, the sex differences in the Gdx levels of AA most
likely reflect actual differences in the number of aromatase neurons
independent of their capacity for hormonal induction and suggest that
greater numbers of aromatase-containing cells are present within
certain regions of the masculinized adult brain. Consistent with this
hypothesis, Wagner and Morell (38) reported that adult male rats tended
to have higher numbers of aromatase mRNA-expressing cells than females,
but not more aromatase mRNA per cell. Likewise, a sex difference in the
number of aromatase-immunoreactive cells has been found in the preoptic
area of adult Japanese quail (41) and shrew (42). Finally, Beyer and
Hutchison (43) have shown that numbers of aromatase-immunoreactive
neurons are higher in hypothalamic cultures originating from male
compared with female mice.
Interestingly, perinatal exposure to TP, but not DES, masculinized the
basal levels of AA in the BNST and PVPOA. This observation contrasts
with our finding that both TP and DES exposure masculinized the
capacity for androgen induction of AA in these nuclei as well as in
PVPOA and MPN. The fact that these two end points (i.e.
basal and androgen-induced aromatase) can be differentially affected by
perinatal steroid exposure suggests that they may represent independent
processes that have different hormonal requirements for
differentiation. Both end points appear to be sexually differentiated
by androgen, but aromatization may be required to determine the
capacity for induction of aromatase by androgen, i.e.
androgen responsiveness, whereas androgen per se may
determine the absolute number of aromatase neurons that develop or
survive. There are precedents for considering that both local estrogen
synthesis and unmetabolized androgens contribute to male-specific
developmental processes in the perinatal brain. Locally synthesized
estrogens are thought to irreversibly masculinize the size and
connectivity of several brain nuclei, including the sexually dimorphic
nucleus of the preoptic area (44). On the other hand, T, not its
aromatized metabolites, affects the survival of neurons in the spinal
nucleus of the bulbocavernosis (10). Moreover, it was recently
demonstrated that T treatment increases the absolute number of
aromatase-immunoreactive neurons in hypothalamic cultures and that,
unlike estrogen, T stimulated their morphological differentiation (45).
Taken together, these studies suggest that androgen and estrogen exert
independent, perhaps complementary, effects on the developing brain
that, in turn, affect the basal levels and androgen responsiveness of
aromatase in the adult.
Rats that were Gdx on PD 56 exhibited significantly higher levels of
basal and T-stimulated aromatase in BNST, MPN, and PVPOA than rats that
were Gdx on PD30. This effect was observed regardless of sex or
perinatal treatment. In VMN, the effects of perinatal T treatments
reached significance only in the group that was Gdx on PD 56. These
data suggest that peripubertal exposure to gonadal secretions can
enhance the expression of AA in certain areas of the adult brain, which
may, in turn, enhance adult responsiveness to T. There was no effect of
prepubertal Gdx on the expression of aromatase in AH or MA, indicating
that this response was exerted in a regionally specific manner. The
nature of the effect we observed was subtle and appeared to be
secondary to the effect exerted by perinatal androgen exposure.
However, if confirmed, this observation may help explain the results of
earlier behavioral studies which demonstrated that pubertal exposure to
testosterone sensitizes the neural circuits mediating male sexual
behavior to the activational effects of T in adulthood (25, 26, 27, 46).
In conclusion, the present experiment has demonstrated that AA in the
neural centers mediating masculine sexual behavior is sexually
differentiated in the rat. We have shown that manipulations of the
early hormonal milieu, which are known to differentiate sexual
behavior, also irreversibly determine the capacity for aromatization in
the adult. The process that differentiates aromatase appears to depend
on androgen exposure and in part local estrogen synthesis and is brain
region specific. As the activation of copulation by androgen requires
aromatization of T to estradiol (47, 48, 49), this quantitative enzymatic
difference between sexes could contribute in part to the greater
behavioral responsiveness displayed by males. Finally, our data suggest
that although exposure of the brain to steroid hormones during
perinatal life appears to be necessary for sexual differentiation of
aromatase expression to occur, gonadal hormones also appear to exert
additional effects during puberty.

View larger version (28K):
[in this window]
[in a new window]
|
Figure 3. Effects of perinatal treatments on T-stimulated AA
in the MPN. A, Rats Gdx on PD30. B, Rats Gdx on PD56. Data are
presented as the mean (bars) ± SEM
(lines; n = 47/group). Three-way ANOVA revealed
significant main effects of perinatal treatment (F4,104 =
4.20; P < 0.005), age at castration
(F1,104 = 9.67; P < 0.005), and adult
T treatment (F1,104 = 276; P < 0.0001)
on AA. Newman-Keuls post-hoc comparisons were made
between perinatal treatment groups. See Fig. 2 for symbol
designations.
|
|

View larger version (31K):
[in this window]
[in a new window]
|
Figure 4. Effects of perinatal treatments on T-stimulated AA
in the PVPOA. A, Rats Gdx on PD30. B, rats Gdx on PD56. Data are
presented as the mean (bars) ± SEM
(lines; n = 47/group). Three-way ANOVA revealed
significant main effects of perinatal treatment (F4,103 =
18.74; P < 0.0001), age at castration
(F1,103 = 8.26; P < 0.005, and adult T
treatment (F1,103 = 312; P < 0.0001),
and a significant interaction between perinatal treatment and adult
treatment (F4,103 = 4.88; P < 0.005).
Newman-Keuls post-hoc comparisons were made between
perinatal treatment groups. See Fig. 2 for symbol designations.
|
|

View larger version (34K):
[in this window]
[in a new window]
|
Figure 5. Effects of perinatal treatments on T-stimulated AA
in the VMN. A, Rats Gdx on PD30. B, Rats Gdx on PD56. Data are
presented as the mean (bars) ± SEM
(lines; n = 47/group). Three-way ANOVA revealed
significant main effects of perinatal treatment (F4,101 =
3.30; P < 0.05), age at castration
(F1,101 = 8.53; P < 0.005), and adult
T treatment (F1,101 = 206; P < 0.0001)
and a significant interaction between perinatal treatment and adult
treatment (F4,101 = 4.25; P < 0.005).
Newman-Keuls post-hoc comparisons were made between
perinatal treatment groups. See Fig. 2 for symbol designations.
|
|
 |
Acknowledgments
|
|---|
The authors gratefully acknowledge the valuable assistance of
Joan West, recipient of an NSF Research Experience for Undergraduate
award, and Jobin Nash, recipient of an American Heart Summer Fellowship
award.
 |
Footnotes
|
|---|
1 This work was supported by NSF Grant IBN-9421759 (to C.E.R.) and NIH
Grant P30-HD-18185. 
Received January 26, 1998.
 |
References
|
|---|
-
Mode A, Gustafsson J-A, Sodersten P, Eneroth P 1984 Sex differences in behavioral androgen sensitivity: possible role
of androgen metabolism. J Endocrinol 100:245248[Abstract]
-
Roselli CE 1991 Sex differences in androgen
receptors and aromatase activity in microdissected regions of the rat
brain. Endocrinology 128:13101316[Abstract]
-
Debold JF, Clemens LG 1978 Aromatization and the
induction of male sexual behavior in male, female, and androgenized
female hamsters. Horm Behav 11:401413[CrossRef][Medline]
-
Czaja JA 1984 Sex differences in the activational
effects of gonadal hormones on food intake and body weight. Physiol
Behav 33:553558[CrossRef][Medline]
-
MacLusky NJ, Naftolin F 1981 Sexual
differentiation of the central nervous system. Science 211:12941302[Abstract]
-
Grady KL, Phoenix CH, Young WC 1965 Role of the
developing rat testis in differentiation of the neural tissues
mediating mating behavior. J Comp Physiol Psychol 59:176182[CrossRef][Medline]
-
Sachs BD, Pollak EI, Krieger MS, Barfield RJ 1973 Sexual behavior: normal male patterning in androgenized female rats.
Science 181:770771[Abstract/Free Full Text]
-
Ward IL 1969 Differential effect of pre- and
postnatal androgen on the sexual behavior of intact and spayed female
rats. Horm Behav 1:2536
-
Gray GD, Davis HN, Dewsbury DA 1976 Masculine
sexual behavior in male and female rats following perinatal
manipulation of androgen: effects of genital anesthetization and sexual
experience. Horm Behav 7:317329[CrossRef][Medline]
-
Breedlove SM 1992 Sexual dimorphism in the
vertebrate nervous system. J Neurosci 12:41334142[Medline]
-
Goy RW, McEwen BS 1980 Sexual Differentiation of
the Brain. MIT Press, Cambridge
-
De Vries GJ 1990 Sex differences in
neurotransmitter systems. J Neuroendocrinol 2:113
-
Reisert I, Pilgrim C 1991 Sexual differentiation of
monoaminergic neurons-genetic or epigenetic? Trends Neurosci 14:468473[CrossRef][Medline]
-
McGinnis MY, Katz SE 1996 Sex differences in
cytosolic androgen receptors in gonadectomized male and female rats.
J Neuroendocrinol 8:193197[CrossRef][Medline]
-
Herbison AE 1995 Sexually dimorphic expression of
androgen receptor immunoreactivity by somatostatin neurones in rat
hypothalamic periventricular nucleus and bed nucleus of the stria
terminalis. J Neuroendocrinol 7:543553[CrossRef][Medline]
-
Lisciotto CA, Morrell JI 1994 Sex differences in
the distribution and projections of testosterone target neurons in the
medial preoptic area and the bed nucleus of the stria terminalis of
rats. Horm Behav 28:492502[CrossRef][Medline]
-
Naftolin F, Ryan KJ, Davies IJ, Reddy VV, Flores F,
Petro Z, Kuhn M, White RJ, Takaoka Y, Wolin L 1975 The formation
of estrogens by central neuroendocrine tissues. Recent Prog Horm Res 31:295319
-
Selmanoff MK, Brodkin LD, Weiner RI, Siiteri PK 1977 Aromatization and 5
-reduction of androgens in discrete
hypothalamic and limbic regions of the male and female rat.
Endocrinology 101:841848[Abstract]
-
Roselli CE, Horton LE, Resko JA 1985 Distribution
and regulation of aromatase activity in the rat hypothalamus and limbic
system. Endocrinology 117:24712477[Abstract]
-
Sachs BD, Meisel RL 1994 The physiology of male
sexual behavior. In: Knobil E, Neil J (eds) The Physiology of
Reproduction. Raven Press, New York, pp 3105
-
Roselli CE, Salisbury RL, Resko JA 1987 Genetic
evidence for androgen-dependent and independent control of aromatase
activity in the rat brain. Endocrinology 121:22052210[Abstract]
-
Abdelgadir SE, Resko JA, Ojeda SR, Lephart ED, McPhaul
MJ, Roselli CE 1994 Androgens regulate aromatase cytochrome P450
messenger ribonucleic acid in rat brain. Endocrinology 135:395401[Abstract]
-
Roselli CE, Klosterman SA, Fasasi TA 1996 Sex
differences in androgen responsiveness in the rat brain: regional
differences in the induction of aromatase activity. Neuroendocrinology 64:139145[Medline]
-
Roselli CE, Abdelgadir SE, Jorgensen E, Resko JA 1996 Sex differences in androgen regulated cytochrome P450 aromatase
mRNA in the rat brain. Endocrine 5:5965
-
Sisk CL, Berglund LA, Tang YA, Venier JE 1992 Photoperiod modulates pubertal shifts in behavioral responsiveness to
testosterone. J Biol Rhythms 7:329339[Abstract/Free Full Text]
-
Sodersten P, Damassa DA, Smith ER 1977 Sexual
behavior in developing male rats. Horm Behav 8:320341[CrossRef][Medline]
-
Baum MJ 1972 Precocious mating in male rats
following treatment with androgen or estrogen. J Comp Physiol
Psychol 78:356367[CrossRef][Medline]
-
Dohler KD, Coquelin A, Davis F, Hines M, Shryne JE,
Gorski RA 1984 Pre- and postnatal influence of testosterone
propionate and diethylstilbestrol on differentiation of the sexually
dimorphic nucleus of the preoptic area in male and female rats. Brain
Res 302:291295[CrossRef][Medline]
-
Roselli CE, Ellinwood WE, Resko JA 1984 Regulation
of brain aromatase activity in rats. Endocrinology 114:192200[Abstract]
-
Palkovits M, Brownstein MJ 1988 Maps and Guide to
Microdissection of the Rat Brain. Elsevier, New York
-
Roselli CE, Resko JA 1991 In vitro assay
of aromatase activity in the central nervous system. In: Greenstein B
(ed) Neuroendocrine Research Methods. Harwood, Chur, Switzerland, vol 2:937951
-
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein determination with the Folin phenol reagent. J Biol Chem 193:265267[Free Full Text]
-
Resko JA, Malley A, Begley D, Hess DL 1973 Radioimmunoassay of testosterone during fetal development of the rhesus
monkey. Endocrinology 93:156161[Medline]
-
Winer BJ 1962 Statistical Principles in
Experimental Design. McGraw-Hill, New York
-
Steimer T, Hutchison JB 1990 Is androgen-dependent
aromatase activity sexually differentiated in the rat and dove preoptic
area. J Neurobiol 21:787795[CrossRef][Medline]
-
Roselli CE, Abdelgadir SE, Resko JA 1997 Regulation
of aromatase gene expression in the adult rat brain. Brain Res Bull 44:351357[CrossRef][Medline]
-
Sar M, Stumpf WE 1975 Distribution of
androgen-concentrating neurons in rat brain. In: Stumpf WE, Grant LD
(eds) Anatomical Neuroendocrinology. Karger, Basel, pp 120133
-
Wagner CK, Morrell JI 1996 Distribution and
steroid hormone regulation of aromatase mRNA expression in the
forebrain of adult male and female rats: a cellular-level analysis
using in situ hybridization. J Comp Neurol 370:7184[CrossRef][Medline]
-
Simerly RB 1993 Distribution and regulation of
steroid hormone receptor gene expression in the central nervous system.
Adv Neurol 59:207226[Medline]
-
Tsuruo Y, Ishimura K, Fujita H, Osawa Y 1994 Immunocytochemical localization of aromatase-containing neurons in the
rat brain during pre- and postnatal development. Cell Tissue Res 278:2939[Medline]
-
Foidart A, De Clerck A, Harada N, Balthazart J 1994 Aromatase-immunoreactive cells in the quail brain: effects of
testosterone and sex dimorphism. Physiol Behav 55:453464[CrossRef][Medline]
-
Rissman EF, Harada N, Roselli CE 1996 Effect of
vorozole, an aromatase enzyme inhibitor, on sexual behavior, aromatase
activity and neural immunoreactivity. J Neuroendocrinol 9:199210[CrossRef]
-
Beyer C, Green SJ, Hutchison JB 1994 Androgens
influence sexual differentiation of embryonic mouse hypothalamic
aromatase neurons in vitro. Endocrinology 135:12201226[Abstract]
-
Gorski RA 1985 Sexual differentiation of the brain:
possible mechanisms and implications. Can J Physiol Pharmacol 63:577594[Medline]
-
Beyer C, Hutchison JB 1997 Androgens stimulate the
morphological maturation of embryonic hypothalamic
aromatase-immunoreactive neurons in the mouse. Dev Brain Res 98:7481[CrossRef][Medline]
-
Larsson K 1967 Testicular hormone and developmental
changes in mating behavior of the male rat. J Comp Physiol Psychol 63:223230[CrossRef][Medline]
-
Lephart ED, Simpson ER, McPhaul MJ 1992 Ovarian
aromatase cytochrome P-450 mRNA levels correlate with enzyme
activity and serum estradiol levels in anestrous, pregnant and
lactating rats. Mol Cell Endocrinol 85:205214[CrossRef][Medline]
-
Clancy AN, Zumpe D, Michael RP 1995 Intracerebral
infusion of an aromatase inhibitor, sexual behavior and brain estrogen
receptor-like immunoreactivity in intact male rats. Neuroendocrinology 61:98111[CrossRef][Medline]
-
Vagell ME, McGinnis MY 1997 The role of
aromatization in the restoration of male rat reproductive behavior.
J Neuroendocrinol 9:415421[CrossRef][Medline]
This article has been cited by other articles:

|
 |

|
 |
 
C. Bodo and E. F. Rissman
The Androgen Receptor Is Selectively Involved in Organization of Sexually Dimorphic Social Behaviors in Mice
Endocrinology,
August 1, 2008;
149(8):
4142 - 4150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Foecking, M. Szabo, N. B. Schwartz, and J. E. Levine
Neuroendocrine Consequences of Prenatal Androgen Exposure in the Female Rat: Absence of Luteinizing Hormone Surges, Suppression of Progesterone Receptor Gene Expression, and Acceleration of the Gonadotropin-Releasing Hormone Pulse Generator
Biol Reprod,
June 1, 2005;
72(6):
1475 - 1483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Omoto, R. Lathe, M. Warner, and J.-A. Gustafsson
Early onset of puberty and early ovarian failure in CYP7B1 knockout mice
PNAS,
February 22, 2005;
102(8):
2814 - 2819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Matagne, G. Rasier, M.-C. Lebrethon, A. Gerard, and J.-P. Bourguignon
Estradiol Stimulation of Pulsatile Gonadotropin-Releasing Hormone Secretion in Vitro: Correlation with Perinatal Exposure to Sex Steroids and Induction of Sexual Precocity in Vivo
Endocrinology,
June 1, 2004;
145(6):
2775 - 2783.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Roselli, K. Larkin, J. A. Resko, J. N. Stellflug, and F. Stormshak
The Volume of a Sexually Dimorphic Nucleus in the Ovine Medial Preoptic Area/Anterior Hypothalamus Varies with Sexual Partner Preference
Endocrinology,
February 1, 2004;
145(2):
478 - 483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kishida and G. V. Callard
Distinct Cytochrome P450 Aromatase Isoforms in Zebrafish (Danio rerio) Brain and Ovary Are Differentially Programmed and Estrogen Regulated during Early Development
Endocrinology,
February 1, 2001;
142(2):
740 - 750.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Gomez and M. F. Dallman
Manipulation of androgens causes different energetic responses to cold in 60- and 40-day-old male rats
Am J Physiol Regulatory Integrative Comp Physiol,
January 1, 2001;
280(1):
R262 - R273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Romeo, J. Wade, J. E. Venier, and C. L. Sisk
Androgenic Regulation of Hypothalamic Aromatase Activity in Prepubertal and Postpubertal Male Golden Hamsters
Endocrinology,
January 1, 1999;
140(1):
112 - 117.
[Abstract]
[Full Text]
|
 |
|